Evidence map›Paper›PMID 19822795›Full record

ArticleHypertension (Dallas, Tex. : 1979)2009

Glutathione S-transferase-micro1 regulates vascular smooth muscle cell proliferation, migration, and oxidative stress.

Yanqiang Yang, Kelly K Parsons, Liqun Chi, Sandra M Malakauskas, Thu H Le

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Integrated Single-Cell Multi-Omics Analysis Reveals That a CD8International journal of molecular sciences · 2026
    Article
  5. Integrative Transcriptomic and Proteomic Analysis RevealsAnimals : an open access journal from MDPI · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  12. Association of GSTM1 Deletion With Progression of CKD in Children: Findings From the Chronic Kidney Disease in Children (CKiD) Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Observational
  13. Article
  14. Hypertension (Dallas, Tex. : 1979) · 2021
    Review
  15. Article
  16. Journal of the American Society of Nephrology : JASN · 2020
    Article
  17. Review
  18. Frontiers in genetics · 2019
    Article
  19. The Loss ofJournal of the American Society of Nephrology : JASN · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yanqiang YangUniversity of Virginia, Box 800133, Charlottesville, VA 22908, USA.
Kelly K Parsons
Liqun Chi
Sandra M Malakauskas
Thu H Le
University of Alabama at Birmingham · US

Funding

Genes That Regulate Progression of Kidney Disease and Its Cardiovascular EffectsR01DK075035 · NIDDK · UNIVERSITY OF VIRGINIA · PI LE, THU H. · 2007 to 2011
$1.6M
NIDDK NIH HHS DK075035NIDDK NIH HHS R01 DK075035
6 · The paper itself

Abstract

Glutathione S-transferase-micro1, GSTM1, belongs to a superfamily of glutathione S-transferases that metabolizes a broad range of reactive oxygen species and xenobiotics. Across species, genetic variants that result in decreased expression of the Gstm1 gene are associated with increased susceptibility for vascular diseases, including atherosclerosis in humans. We previously identified Gstm1 as a positional candidate in our gene mapping study for susceptibility to renal vascular injury characterized by medial hypertrophy and hyperplasia of the renal vessels. To determine the role of Gstm1 in vascular smooth muscle cells (VSMCs), we isolated VSMCs from mouse aortas. We demonstrate that VSMCs from the susceptible C57BL/6 mice have reduced expression of Gstm1 mRNA and its protein product compared with that of the resistant 129 mice. After serum stimulation, C57BL/6 VSMCs proliferate and migrate at a much faster rate than 129 VSMCs. Furthermore, C57BL/6 VSMCs have higher levels of reactive oxygen species and exhibit exaggerated p38 mitogen-activated protein kinase phosphorylation after exposure to H(2)O(2). To establish causality, we show that knockdown of Gstm1 by small interfering RNA results in increased proliferation of VSMCs in a dose-dependent manner, as well as in increased reactive oxygen species levels and VSMC migration. Moreover, Gstm1 small interfering RNA causes increased p38 mitogen-activated protein kinase phosphorylation and attenuates the antiproliferative effect of Tempol. Our data suggest that Gstm1 is a novel regulator of VSMC proliferation and migration through its role in handling reactive oxygen species. Genetic variants that cause a decremental change in expression of Gstm1 may permit an environment of exaggerated oxidative stress, leading to susceptibility to vascular remodeling and atherosclerosis.

Indexed as

AnimalsAntioxidantsAortaAtherosclerosisCell DivisionCell MovementCells, CulturedCyclic N-OxidesGlutathione TransferaseHydrogen PeroxideMiceMice, Inbred C57BLMuscle, Smooth, VascularOxidantsOxidative Stressp38 Mitogen-Activated Protein KinasesAntioxidantsCyclic N-OxidesGlutathione TransferaseHydrogen PeroxideOxidantsp38 Mitogen-Activated Protein KinasesReactive Oxygen SpeciesRNA, Small InterferingSpin Labelstempol

Identifiers

PMID19822795
PMCPMC2783903
OpenAlexW2104098529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.